Adverse experiences are reported as required by the IRB at each site. There are no additional US Food and Drug Administration regulations because we are not studying a biological agent. The Manual of Operations includes detailed definitions of adverse experiences, a table for grading their severity, and details of how clinical sites are to report them.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.